In previous studies, intrahepatic human biliary epithelial cells (BEC) were isolated in high purity. However, these cells demonstrated only limited growth responses. Here we report that human BEC proliferate in response to human hepatocyte growth factor (hHGF), retain BEC-specific phenotype, and can be serially passaged. BEC showed dose-dependent growth in response to 0.01-100 ng/ml hHGF. The maximum S-phase labeling index reached 40% with half-maximal stimulation at 1 ng/ml. The response of cells from normal and primary biliary cirrhotic liver to hHGF was similar. Cultures were immunostained with specific antibodies and then processed for [3H]thymidine autoradiography. Proliferating cells expressed BEC-specific markers (HEA125 and CK-19), but were negative for desmin and factor VIII-related antigen. Occasional vimentin-positive cells were observed, but these were nonproliferative. In conclusion, cells responding to hHGF were clearly BEC in origin. The observation that HGF is mitogenic for BEC as well as hepatocytes has important implications. First, greater yields of intrahepatic BEC are available for subsequent studies of the pathogenesis and etiology of diseases of the biliary epithelium. Secondly, some means of regulating the cellular response to HGF in vivo must operate, in that HGF levels rise early after partial hepatectomy and yet BEC proliferate 24 h later than hepatocytes.
Introduction
To overcome the complexities of whole-animal experimentation, in recent years the regulation ofmammalian liver regeneration has been investigated by means of in vitro approaches ( 1, 2) . Studies have focused upon the agents (nutrients, hor-A preliminary report ofthis work was presented at the 42nd Meeting of the American Association for the Study of Liver Diseases, 25 November 1991, Chicago, IL and published in abstract form ( 1991. Hepa- tology. 14 mones, and growth factors) that initiate or potentiate DNA synthesis and cell division in isolated hepatocytes, inasmuch as this cell population is the first to respond mitogenically to the growth signals in vivo (3) . In the rat, hepatocytes traverse from growth quiescence to S-phase with a first peak of DNA synthesis after 16-18 h, mitosis following some 6 h later (4) . The other cell types of the liver, including biliary epithelial cells (BEC),' endothelial cells, and lipocytes, are said to proliferate with a lag ofa further 24 h (4). Owing chiefly to the difficulty in preparing homogeneous populations of these other cell types, their growth and functional characteristics have not been studied as extensively. However, lipocytes, Kupffer cells, and endothelial cells can be isolated satisfactorily from normal rat liver (5, 6) , whereas the model of choice for BEC isolation remains that of the bile duct ligated rat (7) .
With access to both normal and diseased human liver tissue through the clinical transplantation program in this unit, our recent work has concentrated on the growth regulation of human liver cells. These studies have led us to conclude that many ofthe factors that are active in stimulating rat hepatocyte growth also retain bioactivity on isolated human hepatocytes although some important species differences are evident (8, 9) . We have also developed a method which yields highly pure preparations of BEC from normal and diseased human liver (10, 11) . However, although BEC isolated from rat liver will proliferate in culture (7), isolated human cells have proven difficult to maintain in vitro (10) (11) (12) (13) . Even in the presence of enriched media, human BEC, in keeping with other epithelial cell types including keratinocytes and cervical epithelium ( 14, 15) , require feeder-layer fibroblasts for survival. Furthermore, human BEC demonstrate only limited growth and do not survive more than one passage (10, 11) .
Hepatocyte growth factor (HGF) is a high molecular mass growth factor (95 kD) and is the most potent mitogen yet found for hepatocytes in vitro (8, (16) (17) (18) (19) . Recently HGF has been shown to be identical to lung fibroblast growth factor (20) , indicating that it is not liver specific. Indeed HGF acts as a mitogen for epithelial cells from a number oftissues (20) (21) (22) and a wide tissue distribution of the polypeptide has recently been reported (23) . Additionally, scatter factor, which induces epithelial and endothelial cell migration (24) , is also identical to HGF (25) . However, despite its ubiquitous presence, HGF is thought by some investigators to be the primary mitogen that initiates the growth response in hepatocytes after partial hepatectomy or tissue injury ( 16, 26) . In this report, we present data that indicate that human BEC proliferate in response to HGF, which heretofore has been considered to be growth specific at least in the liver for hepatocytes ( 17, 18, 26).
Methods
Hepatocyte growth factor. Recombinant human HGF was purified from Chinese hamster ovary cell transfectants as previously described (8) .
Isolation and culture ofhuman biliary epithelial cells. Normal liver was obtained from reduced grafts used for pediatric liver transplant recipients. Donor organs had been perfused with University ofWisconsin preservation fluid (27) and maintained at 40C for 12-24 h before cell isolation. Primary biliary cirrhosis (PBC) liver (histological stage III and IV) was from hepatectomy specimens obtained through the orthotopic liver transplantation program.
Isolation of intrahepatic BEC from human liver is described in detail elsewhere (10, 11) . Briefly, -30 g of liver was collagenase digested, followed by immunomagnetic purification of BEC using a monoclonal antibody, HEA125 (Progen Biotechnik, Heidelberg, FRG). This antibody recognizes an M, 34,000 KD cell surface glycoprotein expressed by epithelial cells from numerous tissues (28) but absent from mesenchymal and mesothelial cells (28). In the liver, however, hepatocytes are negative and HEA 125 staining is confined to BEC (10, 11, 28) . Additionally, hepatic capsular mesothelial cells were also negative for HEA125 (not shown). Immunoisolated BEC were resuspended in BEC plating medium composed of45% Ham's F12 medium (Gibco Laboratories, Grand Island, NY), 45% Dulbecco's modification of Eagle's medium (DME, Gibco Laboratories), 10% fetal bovine serum (FBS), insulin (5 Ag/ml), epidermal growth factor (10 ng/ml), cholera toxin (10 ng/ml), hydrocortisone (0.4 Atg/ml), triiodothyronine (2 nM), streptomycin (40 ug/ml), and penicillin (24 tg/ml).
The cells were plated in 25-cm3 tissue culture flasks (stock cultures) or 2-cm3 wells (24-well plates for growth assays). After allowing h for attachment, plating medium was replaced with growth medium which contained reduced serum (5% FBS) and hHGF. BEC stocks were cultured in medium supplemented with 10 ng/ml hHGF which was renewed every other day. At confluence, cells were passaged using trypsin and replated at 25% density. For cryopreservation, cells grown in the presence of 10 ng/ml were suspended in freezing medium (50% FBS, 10% dimethyl sulfoxide, 40% DME). They were cooled in the liquid N2 vapor phase overnight and stored at -140°C for up to (29) . Quantitation and statistics. For determination ofthe S-phase labeling index, the plates were examined using an inverted microscope (Olympus Corp., Lake Success, NY) fitted with an eyepiece graticule and a X20 objective. Three separate fields in each of a minimum of triplicate wells were scored for labeled and unlabeled nuclei (minimum of nine fields at each concentration of hHGF, representing between 300 and 500 cells). The method was validated by comparing the scores with those oftwo other independent scorers. Friedman analysis showed no difference in the distribution of the three sets of scores (P = 0.14)
and Wilcoxon signed rank analysis of pairs showed no significant difference between the scores (P > 0.7). The data presented represents the mean score±standard deviation of the three independent scorers. Responses to hHGF were analyzed using Wilcoxon (Fig.  1 ). Maximal growth ofBEC was seen at 10-100 ng/ml hHGF, with a reduction at higher doses (Fig. 1) . After autoradiography, the S-phase labeling index of BEC cultures rose markedly (Fig. 2) . At lower doses, labeled cells were located predominantly near the edges of colonies (Fig. 2 b) . However at high doses, cells in the center of confluent monolayers also labeled strongly (Fig. 2, c and d) . The S-phase LI rose to a maximum of -40% between 10 and 100 ng/ml hHGF (Fig. 3) . However, increased proliferation could be detected with as little as 0.01-0.1 ng/ml hHGF (Fig. 3) . Half-maximal stimulation occurred at -1 ng/ml. In keeping with our previous observations that cells isolated from both normal and PBC livers retained similar morphological and functional characteristics ( 10, 11) , the growth responses to hHGF of both populations were indistinguishable (Figs. 3 and 4). At 10 ng/ml hHGF the degree of stimulation of BEC from eight subjects (three normals and five PBCs) was similar (Fig. 4) . HEA 125 (Fig. 5, a and b) , both specific in the liver for biliary cells. HEA 125 staining was clearly membranous (Fig. 5 a) while CK-19 was cytoplasmic (Fig. 5 b) , consistent with their expected cellular localisation. HEA 125 and CK-19 expression could be detected in BEC which had been grown, and passaged at least twice, in the presence of 10 ng/ml hHGF for 3 wk (results not shown). Concentration hHGF (ng/ml) 
Discussion
The development of a reliable technique to isolate homogeneous populations ofhuman intrahepatic biliary epithelial cells (10, 11 ) has led to novel experimental studies into the etiology of diseases of the biliary epithelium ( 30, 31 Figure 4 . The response of BEC from three normal subjects (dashed lines) and five PBC patients (solid lines) to 10 ng/ml hHGF. The mean labeling index of hHGF-treated cells was higher than that of untreated cells (P < 0.01 Wilcoxon signed rank test).
which to conduct such studies. Human HGF-treated BEC no longer require fibroblast feeder-layer support (10, 11) , can be serially passaged, and can be successfully cryopreserved and stored for future studies.
Recent developments indicate that hHGF is not solely a mitogen for hepatocytes, but stimulates the growth ofepithelial cells from kidney, breast, lung, and skin (20) (21) (22) . In addition, both HGF mRNA and protein have been detected in a wide array ofcells and tissues ( 18, 23) . Notably, although expressed and released by fibroblasts, it appears to have little bioactivity on cells of mesenchymal origin (20) (21) (22) . Endothelial cells, which proliferate and/or migrate in response to HGF (20, 24) (20, 24) , the reported biological activity of hHGF in vitro has to date been confined to cells of epithelial origin (20) (21) (22) (Fig. 4 c) , it was notable that those cells consistently failed to label with thymidine. Although their precise origin remains in question and it is possible that they represent a minor contaminant from the preparative procedure, this is considered unlikely. Recent reports indicate that vimentin may not be confined to cells ofmesenchymal origin, but can be found in epithelial cells from several different tissues (35) (36) (37) (38) . Moreover, Milani et al. (39) have shown vimentin expression in cells of newly formed rat bile duct epithelial cells after bile duct ligation in the rat. Interestingly, as shown here, they found that a very low percentage of vimentin-positive cells were actively proliferating. Thus we conclude that the small population of t-. vimentin-positive cells identified in the present study may indeed be BEC-derived.
The fact that human BEC respond to hHGF in vitro has important consequences. HGF is strongly implicated in the initiation of liver regeneration in that its expression increases after hepatectomy considerably earlier than the other mitogenic agents. Circulating levels of HGF rise within 1-2 h after hepatectomy in the rat (26) . This HGF is thought to be from extrahepatic sources inasmuch as intrahepatic HGF expression only rises after -3-6 h (40, 41 ). In addition, HGF is the most potent hepatocyte mitogen known (8, (16) (17) (18) (19) . In animals (and probably in human) hepatocytes lead the regenerative response whether induced by toxins, viruses, or surgery with the other cell types including biliary epithelial cells following some 24 h later (3, 4) . Thus, if as is suggested by currently available evidence, hHGF is the primary mitogen in initiating liver regeneration, then it is clearly necessary to invoke some mechanism whereby the response to endocrine (or paracrine) hHGF is restricted to the liver and, furthermore, to a given cell type and/or location within the tissue during the regenerative response.
In this regard, the recent demonstration of HGF receptor expression in both biliary epithelial cells and hepatocytes on histological sections of normal human liver (42) is of interest. Clearly this supports the concept that HGF is an important mitogen for BEC in vivo as well as in culture. However, it also indicates that target cell specificity does not simply rest in the ability of a given cell type to express the receptor. Indeed the HGF receptor has been localized in many different cells and tissues (42) . The mechanism whereby the cell-specific targeting of the biological activity of HGF comes about remains unknown.
